CONMED CORPORATION Standard Product Warranty Accrual, Decrease for Payments
CONMED CORPORATION (CNMD) reported Standard Product Warranty Accrual, Decrease for Payments of $446.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Product Warranties Disclosures
us-gaap:StandardProductWarrantyAccrualPayments · last filed 2026-07-29
- CONMED CORPORATION standard product warranty accrual, decrease for payments for the quarter ending 2025-09-30 was $164.00K, a 23.72% decline year-over-year.
- CONMED CORPORATION standard product warranty accrual, decrease for payments for the quarter ending 2025-06-30 was $215.00K, a 19.44% increase year-over-year.
- CONMED CORPORATION standard product warranty accrual, decrease for payments for the quarter ending 2025-03-31 was $151.00K, a 17.49% decline year-over-year.
- CONMED CORPORATION standard product warranty accrual, decrease for payments for the quarter ending 2024-09-30 was $215.00K, a 11.98% increase year-over-year.
| Period end | Standard Product Warranty Accrual, Decrease for Payments 3 month | Standard Product Warranty Accrual, Decrease for Payments 6 month | Standard Product Warranty Accrual, Decrease for Payments 6 month as first filed | Standard Product Warranty Accrual, Decrease for Payments 9 month | Standard Product Warranty Accrual, Decrease for Payments 9 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $446.00K 10-Q · filed 2026-07-29 | ||||
| 2025-09-30 | $164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $379.00K derived: sum of 2 quarters · filed 2026-07-29 | $530.00K 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $215.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $366.00K 10-Q · filed 2026-07-29 | |||
| 2025-03-31 | $151.00K 10-Q · filed 2025-05-01 | ||||
| 2024-09-30 | $215.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $395.00K derived: sum of 2 quarters · filed 2025-11-06 | $578.00K 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $180.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $363.00K 10-Q · filed 2025-07-31 | |||
| 2024-03-31 | $183.00K 10-Q · filed 2025-05-01 | ||||
| 2023-09-30 | $192.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $371.00K derived: sum of 2 quarters · filed 2024-10-31 | $569.00K 10-Q · filed 2024-10-31 | ||
| 2023-06-30 | $179.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $377.00K 10-Q · filed 2024-08-01 | |||
| 2023-03-31 | $198.00K 10-Q · filed 2024-04-25 | ||||
| 2022-09-30 | $255.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $437.00K derived: sum of 2 quarters · filed 2023-10-26 | $624.00K 10-Q · filed 2023-10-26 | ||
| 2022-06-30 | $182.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $369.00K 10-Q · filed 2023-07-27 | |||
| 2022-03-31 | $187.00K 10-Q · filed 2023-04-27 | ||||
| 2021-09-30 | $243.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $477.00K derived: sum of 2 quarters · filed 2022-10-27 | $683.00K 10-Q · filed 2022-10-27 | ||
| 2021-06-30 | $234.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $440.00K 10-Q · filed 2022-07-28 | |||
| 2021-03-31 | $206.00K 10-Q · filed 2022-05-05 | ||||
| 2020-09-30 | $348.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $569.00K derived: sum of 2 quarters · filed 2021-10-28 | $932.00K 10-Q · filed 2021-10-28 | ||
| 2020-06-30 | $221.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $584.00K 10-Q · filed 2021-07-29 | |||
| 2020-03-31 | $363.00K 10-Q · filed 2021-04-29 | ||||
| 2019-09-30 | $338.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $478.00K derived: sum of 2 quarters · filed 2020-10-29 | $821.00K 10-Q · filed 2020-10-29 | $1.03M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $140.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $483.00K 10-Q · filed 2020-07-30 | $696.00K 10-Q · filed 2019-08-01 | ||
| 2019-03-31 | $343.00K 10-Q · filed 2020-04-30 | ||||
| 2018-09-30 | $326.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $647.00K derived: sum of 2 quarters · filed 2019-10-31 | $937.00K 10-Q · filed 2019-10-31 | ||
| 2018-06-30 | $321.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $611.00K 10-Q · filed 2019-08-01 | |||
| 2018-03-31 | $290.00K 10-Q · filed 2019-04-26 | ||||
| 2017-09-30 | $386.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $628.00K derived: sum of 2 quarters · filed 2018-11-02 | $907.00K 10-Q · filed 2018-11-02 | ||
| 2017-06-30 | $242.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $521.00K 10-Q · filed 2018-08-02 | |||
| 2017-03-31 | $279.00K 10-Q · filed 2018-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |